Komori
Showa Paxxs (3954) · InitiativeAdvanced

Continuation of Research and Development Activities

First written in FY2017-Q1. 22 of 30 entries say "Restated". Latest entry: FY2026.

30entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2018-Q1 – FY2019-Q3RestatedFY2021-Q1 – FY2022-Q3RestatedFY2023-Q1 – FY2024-Q3RestatedFY2025-H1 – FY2026-H12016: 220162017: 420172018: 320182019: 320192020: 420202021: 320212022: 420222023: 220232024: 320242025: 120252026: 12026
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

45 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「R&D expenses for the current consolidated fiscal year were ¥236.782 million. The BAX production equipment introduced at the Tokyo Plant has been operating smoothly and is achieving the targeted level of productivity. The pinch-bag production equipment introduced at the Hofu Plant has also begun operating; most of the problems identified to date have been resolved, and improvements are being made toward stable operation.」

    The company recorded R&D expenses and reported specific progress: the BAX equipment at the Tokyo Plant is operating at the target productivity level, and the pinch-bag equipment at the Hofu Plant has also begun operating.
  2. FY2026-H1RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the interim consolidated accounting period was ¥118 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    The company continued its research and development activities and continued to explain that there have been no material changes in their status.
  3. FY2025-H1RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the interim consolidated accounting period was ¥115 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    The company conducted ¥115 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  4. FY2024AdvancedAnnual report

    「In terms of quality, the company began operating AI-based image inspection systems on 2 production lines in fiscal year 127, while working to further improve inspection accuracy and considering the introduction of image inspection systems at other production facilities.」

    The company began operating an AI-based image inspection system on 2 production lines, improved inspection accuracy, and proceeded to consider rolling it out to other facilities.
  5. FY2024-Q3RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the nine-month period ended Q3 was ¥179 million. There were no material changes in the status of the Group's R&D activities during the nine-month period ended Q3.」

    The company continues its R&D activities and states that there have been no material changes in their status.
  6. FY2024-Q1RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the three-month period ended Q1 was ¥59 million. There were no material changes in the status of the Group's R&D activities during the three-month period ended Q1.」

    The company continues its R&D activities and states that there have been no material changes in their status.
  7. FY2023-Q3Cumulative R&D expenses increasedAnnual report

    「The total amount of R&D activities undertaken by the Group during the nine-month period ended Q3 was ¥212 million.」

    Cumulative R&D expenses amounted to ¥212 million, up from ¥191 million in the same period of the previous year and ¥135 million in the previous quarter. The company states that there have been no material changes in the status of its R&D activities.
  8. FY2023-Q2RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the six-month period ended Q2 was ¥135 million. There were no material changes in the status of the Group's R&D activities during the six-month period ended Q2.」

    The company conducted ¥135 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  9. FY2023-Q1RestatedAnnual report

    「For the first quarter of the current consolidated fiscal year, the Group's total research and development expenditure was ¥68 million. There were no significant changes in the status of the Group's research and development activities during the period.」

    The company continued its research and development activities and continued to explain that there have been no material changes in their status.
  10. FY2022AdvancedAnnual report

    「The company began operating an AI-based image inspection system on a dual-bottom bottomer at the beginning of the current consolidated fiscal year. During the year, it repeatedly retrained the AI to further improve inspection accuracy. As a result, there were 0 claims relating to this process during the current consolidated fiscal year, confirming the usefulness of the AI-based image inspection system. The company is currently proceeding with plans to roll out the AI-based image inspection system horizontally to other processes.」

    The company began operating an AI-based image inspection system, repeatedly retrained the AI, achieved 0 claims in the target process, and is proceeding with plans to roll it out to other processes.
  11. FY2022-Q3RestatedAnnual report

    「For the first nine months of the current consolidated fiscal year, the Group's total research and development expenditure was ¥195 million. There were no significant changes in the status of the Group's research and development activities during the period.」

    The company conducted ¥195 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  12. FY2022-Q2RestatedAnnual report

    「The total amount of R&D activities undertaken by the Group during the six-month period ended Q2 was ¥130 million. There were no material changes in the status of the Group's R&D activities during the six-month period ended Q2.」

    The company conducted ¥130 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  13. FY2022-Q1RestatedAnnual report

    「For the first quarter of the current consolidated fiscal year, the Group's total research and development expenditure was ¥62 million. There were no significant changes in the status of the Group's research and development activities during the period.」

    The company continued its research and development activities and continued to explain that there have been no material changes in their status.
  14. FY2021-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the nine months ended the third quarter was ¥163 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter.」

    The company conducted ¥163 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  15. FY2021-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the six months ended the second quarter was ¥109 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter.」

    The company conducted ¥109 million in R&D activities and continues to state that there have been no material changes in the status of those activities.
  16. FY2021-Q1RestatedAnnual report

    「Group-wide research and development expenditure for the three months ended the first quarter was ¥55 million. There were no material changes in the status of the group's research and development activities during the three months ended the first quarter.」

    The company conducted ¥55 million in research and development activities and continued to explain that there have been no material changes in their status.
  17. FY2020AdvancedAnnual report

    「Research and development expenses for the fiscal year were ¥210.164 million. The company is developing an AI-based automated visual inspection method for the production line for double-bottom pasted bags.」

    The company recorded ¥210.164 million in research and development expenses and advanced specific development and commercialization activities, including AI-based automated visual inspection, sales of shrink film to new customers, and actual transportation testing for Balcon.
  18. FY2020-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the nine months ended the third quarter was ¥160 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter.」

    The company continued its research and development activities and continued to explain that there have been no material changes in their status.
  19. FY2020-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the six months ended the second quarter was ¥107 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter.」

    The company conducted ¥107 million in research and development activities and continued to explain that there have been no material changes in their status.
  20. FY2019AdvancedAnnual report

    「Research and development expenses for the fiscal year were ¥229.914 million. The purpose, content, and results of research by segment are as follows.」

    The company recorded research and development expenses and reported specific activities, including shortening the production process for pinch-bottom pasted bags, improving the quality of BAX bags, new orders and testing for films, domestic production of S-Cube components, and improving the manufacturing environment for inner bags for soft tanks.
  21. FY2019-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the nine months ended the third quarter was ¥175 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  22. FY2019-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the six months ended the second quarter was ¥108 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  23. FY2019-Q1RestatedAnnual report

    「Group-wide research and development expenditure for the three months ended the first quarter was ¥56 million. There were no material changes in the status of the group's research and development activities during the three months ended the first quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  24. FY2018-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the nine months ended the third quarter was ¥163 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter.」

    The company conducted ¥163 million in research and development activities and explicitly stated that there have been no material changes in their status.
  25. FY2018-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the six months ended the second quarter was ¥107 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter.」

    The company conducted ¥107 million in research and development activities and explicitly stated that there have been no material changes in their status.
  26. FY2018-Q1RestatedAnnual report

    「Group-wide research and development expenditure for the three months ended the first quarter was ¥56 million. There were no material changes in the status of the group's research and development activities during the three months ended the first quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  27. FY2017AdvancedAnnual report

    「For new product development, the company developed “SV2” for flour milling applications and pursued expanded sales. SV2 was determined to be commercialized for certain product types, compared with the existing “SV bags.”」

    The company recorded ¥233.172 million in research and development expenses and reported specific progress, including the decision to commercialize SV2, new orders for wide HQF products, and entry into the actual transportation testing stage for S-Cube.
  28. FY2017-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the nine months ended the third quarter was ¥191 million. There were no material changes in the status of the group's research and development activities during the nine months ended the third quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  29. FY2017-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the six months ended the second quarter was ¥121 million. There were no material changes in the status of the group's research and development activities during the six months ended the second quarter.」

    The company explicitly stated that research and development activities are continuing and that there have been no material changes in their status.
  30. FY2017-Q1First statedAnnual report

    「The amount spent on research and development activities by the group as a whole during the cumulative first-quarter period was ¥60 million.」

    The company reported ¥60 million in research and development activities during the quarter.
Moved together

"Enhancing Quality Control and Productivity through Manufacturing Environment Improvements" moved the same way as this thread, in the same document, in 5 of its 30 moves.

544333★123456
  1. ★This thread
  2. 1Enhancing Quality Control and Productivity through Manufacturing Environment Improvements5×
  3. 2Capital expenditure through the acquisition of property, plant and equipment4×
  4. 3Expansion of sales channels for liquid containers4×
  5. 4Improved Earnings and Profitability Despite Declining Revenue3×
  6. 5Acquisition of new demand3×
  7. 6Growth Through New Products, New Markets and New Businesses3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Showa Paxxs yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Continuation of Research and Development Activities | SHOWA PAXXS CORPORATION (3954) | Komori